Ticker Scorecard - TERN Basics Company: Terns Pharmaceuticals, Inc. IPO Date: February 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $340.18M Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 4.17% Avg Daily Range (30 D): $0.13 | 2.87% Avg Daily Range (90 D): $0.17 | 2.90% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): 1.12M Avg Daily Volume (90 D): 1.22M Trade Size Avg Trade Size (Sh.): 110 Avg Trade Size (Sh.) (30 D): 113 Avg Trade Size (Sh.) (90 D): 107 Institutional Trades Total Inst.Trades: 468 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $2.27M Avg Inst. Trade (90 D): $1.69M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.77M Avg Closing Trade (30 D): $.92M Avg Closing Trade (90 D): $1.16M Avg Closing Volume: 209.76K     News Sep 18, 2024 @ 2:07 PM This Small-Cap Stock Has a Promising GLP-1 Drug Wh... Source: David Jagielski Sep 15, 2024 @ 11:21 AM Missed Out on Viking Therapeutics? Buy This Weight... Source: Alex Carchidi Sep 15, 2024 @ 10:09 AM Should You Invest in This Under-the-Radar Weight L... Source: Prosper Junior Bakiny Sep 14, 2024 @ 2:12 PM 1 New Weight Loss Drug Stock to Buy Now With $1,00... Source: Alex Carchidi Sep 11, 2024 @ 2:50 AM Terns Announces Pricing of Upsized $150.15 Million... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.18 $-.28 $-.31 Diluted EPS $-1.18 $-.28 $-.31 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -88.07M $ -21.95M $ -22.74M Operating Income / Loss $ -99.98M $ -24.94M $ -25.54M Cost of Revenue $ $ $ Net Cash Flow $ 232.24M $ 178.64M $ 11.54M PE Ratio